MMF Similar to Conventional Therapies for MN, FSGS

Jody A. Charnow January 01, 2008

A six-month course of treatment with mycophenolate mofetil (MMF) is as effective as conventional therapies for treating membranous nephropathy (MN) and focal segmental glomerulosclerosis (FSGS), according to a pilot study conducted in India.
 

Ethanol May Ease Secondary Hyperparathyroidism Post-Tx

Jody A. Charnow November 01, 2007

Percutaneous ethanol injection therapy (PEIT) is a useful and safe treatment alternative for patients with persistent post-transplant secondary hyperparathyroidism, researchers in Argentina report.
 

Older Age May Increase CKD Risk in Live Kidney Donors

Jody A. Charnow November 01, 2007

Older age and hypertension increase the risk of renal impairment among live kidney donors, according to South Korean researchers.
 

PSA Density Predicts PSA Velocity, UK Study Shows

Jody A. Charnow November 01, 2007

PSA density is an independent determinant of PSA velocity in untreated localized prostate cancer, a study in the UK concluded.
 

One Third of Standard BCG Dose May Be Sufficient

Jody A. Charnow November 01, 2007

One third of the standard dose of bacillus Calmette-Guérin (BCG) could be recommended as adjuvant treatment for intermediate-risk superficial bladder tumors, Spanish researchers say.
 

RRT-Treated ARF in Scotland More Common Than Expected

Jody A. Charnow October 23, 2007

Acute renal failure (ARF) in Scotland occurs more frequently than previously thought, according to new research.
 

Canadian Renal Transplant Data Show Race Disparities

Jody A. Charnow October 23, 2007

Among Canadian dialysis patients, those of East Asian and Indo Asian origin are less likely to receive a renal transplant than white patients, data show.
 

Nystatin Prophylaxis May Benefit CAPD Patients

Jody A. Charnow October 23, 2007

Oral nystatin prophylaxis may prevent antibiotic-related fungal peritonitis (AR-FP) in patients receiving continuous ambulatory peritoneal dialysis (CAPD), researchers in Hong Kong concluded.
 

Treatment Manages CMV in Transplant Recipients

Jody A. Charnow October 23, 2007

Preemptive ganciclovir treatment of cytomegalovirus (CMV) infection in simultaneous pancreas-kidney (SPK) transplant recipients appears to be associated with good long-term outcomes, German researchers report.
 

Fetuin-A Predicts Death Risk in Dialysis Patients

Jody A. Charnow September 01, 2007

Serum levels of fetuin-A are a predictor of all-cause, cardiovascular, and non-cardiovascular mortality in dialysis patients, a Dutch study found.